REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 19th, 2018 • IMMUTEP LTD • Pharmaceutical preparations
Contract Type FiledDecember 19th, 2018 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of December 18, 2018, between Immutep Limited, an Australian corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 19th, 2018 • IMMUTEP LTD • Pharmaceutical preparations • New York
Contract Type FiledDecember 19th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of December 18, 2018, is between Immutep Limited, of Level 12, 95 Pitt Street, Sydney 2000, New South Wales, Australia, an Australian public company incorporated under the laws of the Commonwealth of Australia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers”).
AMERICAN DEPOSITARY SHARES PURCHASE WARRANT IMMUTEP LIMITEDWarrant Agreement • December 19th, 2018 • IMMUTEP LTD • Pharmaceutical preparations
Contract Type FiledDecember 19th, 2018 Company IndustryTHIS AMERICAN DEPOSITARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the three year anniversary of the effective date of a registration statement covering the resale of all of the Warrant Shares underlying the ADSs issuable upon exercise of this Warrant (the “Termination Date”; provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day), but not thereafter, to subscribe for and purchase from Immutep Limited, an Australian public company incorporated under the laws of the Commonwealth of Australia (the “Company”), up to ______ American Depositary Shares (“ADSs”), each ADS representing 100 ordinary shares, no par value, of t